Circassia seeks $285 mln in bumper UK biotech IPO-Reuters
Circassia, a company developing allergy treatments based on a discovery by scientists at Imperial College in London, aims to raise about 175 million pounds ($285 million) of new funds in one of Europe's biggest biotechnology IPOs, Reuters reported.
6 February 2014•2 mins read
